Small-Angle X-ray Scattering for PEGylated Liposomal Doxorubicin Drugs: An Analytical Model Comparison Study
Molecular Pharmaceutics · 2023
DOI: 10.1021/acs.molpharmaceut.3c00396 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2023. Verfasst von Yiwen Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Advanced Research Institute, Chinese Academy of Sciences, Shanghai 201210, China. Hauptthemen laut MEDLINE: Liposomes, Doxorubicin. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Natural Science Foundation of Shanghai, National Natural Science Foundation of China.
Abstract (Originalsprache)
Liposomal delivery systems are recognized as efficient and safe platforms for chemotherapeutic agents, with doxorubicin-loaded liposomes being the most representative nanopharmaceuticals. Characterizing the structure of liposomal nanomedicines in high spatial and temporal resolution is critical to analyze and evaluate their stability and efficacy. Small-angle X-ray scattering (SAXS) is a powerful tool increasingly used to investigate liposomal delivery systems. In this study, we chose a Doxil-like PEGylated liposomal doxorubicin (PLD) as an example and characterized the liposomal drug structure using synchrotron SAXS. Classical analytical models, including the spherical-shell or flat-slab geometries with Gaussian or uniform electron density profiles, were used to model the internal structure of the liposomal membrane. A cylinder model was applied to fit the scattering from the drug crystal loaded in the liposomes. The high-resolution structures of the original drug, Caelyx, and a similar research drug prepared in our laboratory were characterized using these analytical models. The structural parameters of PLDs, including the thickness of the liposomal membrane and morphology of the drug crystal, were further compared. The results demonstrated that both spherical-shell and flat-slab geometries with Gaussian electron density distribution were suitable to elucidate the structural features of the liposomal membrane under a certain range of scattering vectors, while models with uniform electron density distribution exhibited poor fitting performance. This study highlights the technical features of SAXS, which provides structural information at the nanoscale for liposomal drugs. The demonstrated methods are reliable and easy-to-use for the structural analysis of liposomal drugs, which are helpful for a broader application of SAXS in the production and regulation of nanopharmaceuticals.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shanghai Advanced Research Institute, Chinese Academy of Sciences, Shanghai 201210, China.
- Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800, China.
- University of Chinese Academy of Sciences, Beijing 100049, China.
- School of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240, China.
ORCID-Profile: Yiwen Li, Xiaohui Wei
Förderung
- Natural Science Foundation of Shanghai
- National Natural Science Foundation of China
Zitieren
APA
Li, Y., Zhang, J., Song, P., Miao, X., Liu, G., Yang, C., Wei, X., Li, N., & Bian, F. (2023). Small-Angle X-ray Scattering for PEGylated Liposomal Doxorubicin Drugs: An Analytical Model Comparison Study. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.3c00396
Vancouver
Li Y, Zhang J, Song P, Miao X, Liu G, Yang C, et al. Small-Angle X-ray Scattering for PEGylated Liposomal Doxorubicin Drugs: An Analytical Model Comparison Study. Molecular Pharmaceutics. 2023. doi:10.1021/acs.molpharmaceut.3c00396
BibTeX
@article{Li2023,
author = {Li, Yiwen and Zhang, Jianqiao and Song, Panqi and Miao, Xiaran and Liu, Guangfeng and Yang, Chunming and Wei, Xiaohui and Li, Na and Bian, Fenggang},
title = {Small-Angle X-ray Scattering for PEGylated Liposomal Doxorubicin Drugs: An Analytical Model Comparison Study},
journal = {Molecular Pharmaceutics},
year = {2023},
doi = {10.1021/acs.molpharmaceut.3c00396}
}
EUVIMED